![]() |
Volumn 36, Issue 2, 2009, Pages 459-
|
Blockade of interleukin 6 signaling induces marked neutropenia in patients with rheumatoid arthritis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATLIZUMAB;
C REACTIVE PROTEIN;
CENTOCOR;
INFLIXIMAB;
INTERLEUKIN 6;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 6 RECEPTOR;
MONOCLONAL ANTIBODY;
BLOOD;
GROUPS BY AGE;
HUMAN;
INFLAMMATION;
LETTER;
MOUSE;
NEUTROPENIA;
NONHUMAN;
PNEUMONIA;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
DRUG EFFECT;
IMMUNOLOGICAL TOLERANCE;
IMMUNOLOGY;
LEUKOCYTE COUNT;
METABOLISM;
NEUTROPHIL;
NEUTROPHIL CHEMOTAXIS;
PATHOPHYSIOLOGY;
SIGNAL TRANSDUCTION;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
CHEMOTAXIS, LEUKOCYTE;
HUMANS;
IMMUNE TOLERANCE;
IMMUNOSUPPRESSIVE AGENTS;
INTERLEUKIN-6;
LEUKOCYTE COUNT;
NEUTROPENIA;
NEUTROPHILS;
RECEPTORS, INTERLEUKIN-6;
SIGNAL TRANSDUCTION;
|
EID: 64849093693
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: 10.3899/jrheum.080930 Document Type: Letter |
Times cited : (37)
|
References (5)
|